Zapater, A, Pinilla, L, Gracia-Lavedan, E, Targa, A, Torres, G, Mínguez, O, Pascual, L, Cortijo, A, Martínez, D, Benítez, ID, García-Hidalgo, MC, De Batlle, J, Abad, J, Duran-Cantolla, J, Urrutia, A, Mediano, O, Masdeu, MJ, Ordax-Carbajo, E, Masa, JF, De la Peña, M, Mayos, M, Coloma, R, Montserrat, JM, Chiner, E, Roncero, A, Sanz-Rubio, D, Barbé, F, Sánchez-de-la-Torre, M. Unraveling the Molecular Mechanisms of OSA-Related Cardiovascular Event Recurrence: A Post Hoc Analysis From the ISAACC Study. ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(4)DOI:10.1016/j.arbres.2024.09.008. PMID:39438203. IF:9.200(Q1/1D).

Bermudo-Peloche, G, Del Rio, B, Vicens-Zygmunt, V, Bordas-Martinez, J, Hernández, M, Valenzuela, C, Laporta, R, Bobillo, JR, Portillo, K, Millán-Billi, P, Balcells, E, Badenes-Bonet, D, Bolivar, S, Rodríguez-Portal, JA, Ramirez, CL, Tomás, L, Roitegi, KFD, Sellarés, J, Castillo, D, González, J, Barril, S, Gutiérrez-Rodríguez, Y, Caballero, P, Alarcon, J, Peñafiel, J, Sanz-Santos, J, Blavia, R, Caupena, C, Segovia, P, Santos-Pérez, S, Ferrer-Artola, A, Badia, MB, Hereu, P, Fuentes, M, Montes-Worboys, A, Franquet, T, Luburich, P, Molina-Molina, M. Pirfenidone in post-COVID-19 pulmonary fibrosis (FIBRO-COVID): a phase 2 randomised clinical trial. EUROPEAN RESPIRATORY JOURNAL. 2025; 65(4)DOI:10.1183/13993003.02249-2024. PMID:40154560. IF:21.000(Q1/1D).

Rogg, L, Nuñez, SA, Mingrone, MVO, Domingo, P, Lopez, M, Hanan, N, Ghita, GL, Jeffrey, JL, Underwood, M, Castillo-Mancilla, JR, Halliday, F, Ezeadi, E, Gartland, M. Antiviral effect, safety, and tolerability of the third-generation integrase strand transfer inhibitor VH4524184 (VH-184): a proof-of-concept trial. HIV MEDICINE. 2025; 26DOI:. PMID:. IF:3.200(Q2/4D).

Tibau, A, Romano, A, Kesselheim, AS. Will I feel better? Raising the bar for quality of life in oncology. Nature Reviews Clinical Oncology. 2025; 22(4)DOI:10.1038/s41571-025-01002-4. PMID:40021787. IF:82.200(Q1/1D).

Del Muro, XG, López-Bravo, DP, Cuéllar-Rivas, MA, Maroto, P, Giannatempo, P, Castellano, D, Climent, MA, Valderrama, BP, de Liaño, AG, López-Montero, L, Mina, L, Alcalá-López, D, Sampayo-Cordero, M, Necchi, A. Retifanlimab in Advanced Penile Squamous Cell Carcinoma: The Phase 2 ORPHEUS Study. European Urology Oncology. 2025; 8(2)DOI:10.1016/j.euo.2024.04.021. PMID:38749903. IF:9.300(Q1/1D).

Soo, RA, Vervita, K, Früh, M, Cho, B, Majem, M, Abreu, DR, Ribi, K, Callejo, A, Moran, T, Gomez, MD, Provencio, M, Addeo, A, Han, JY, Granados, ALO, Reck, M, Blasco, A, Campelo, RG, González, MAS, Britschgi, C, Roschitzki-Voser, H, Ruepp, B, Gasca-Ruchti, A, Haberecker, M, Dafni, U, Peters, S, Stahel, RA. A randomised non-comparative phase II study of atezolizumab, bevacizumab and chemotherapy in EGFR-mutant NSCLC with acquired resistance - The ETOP 15-19 ABC-lung trial. LUNG CANCER. 2025; 202DOI:10.1016/j.lungcan.2025.108454. PMID:40023017. IF:4.400(Q1/2D).

Holgado, A, Casasayas, M, Llansana, A, Gras, JR. Woake's Syndrome Abscessed in Adults: Case Report. Indian Journal of Otolaryngology and Head & Neck Surgery. 2025; 77(4)DOI:10.1007/s12070-024-05285-4. PMID:40226287. IF:0.054(Q4/10D).

Spyridonidis, A, Labopin, M, Savani, BP, Kulagin, A, Blaise, D, Broers, AEC, Sica, S, Raiola, AM, Vydra, J, Choi, G, Rovira, M, Kwon, M, Sanz, J, Itäla-Remes, M, von dem Borne, P, Esquirol, A, Koc, Y, Brissot, E, Nagler, A, Mohty, M, Ciceri, F. The impact of individual comorbidities in transplant recipients receiving post-transplant cyclophosphamide. BONE MARROW TRANSPLANTATION. 2025; 60(4)DOI:10.1038/s41409-025-02514-4. PMID:39910175. IF:5.200(Q1/1D).